Table of Contents
Chapter- 1: SUMMARY
- SUMMARY TABLE GLOBAL DRUGS OF ABUSE TESTING MARKET FORECAST, BY REGION,
THROUGH 2014 ($ MILLIONS)
- SUMMARY FIGURE GLOBAL DRUGS OF ABUSE TESTING MARKET FORECAST BY REGION,
2006- 2014 ($ MILLIONS)
Chapter- 2: OVERVIEW
- DRUG ABUSE TESTING
- INTRODUCTION
- INTERNATIONAL DRUG TRAFFICKING AND ILLICIT DRUG USE TRENDS BY DRUG TYPE
- TABLE 1 NUMBER OF ILLICIT DRUG USERS GLOBALLY, 2003- 2007 (MILLIONS)
- TABLE 2 GLOBAL DRUG SEIZURES BY COUNTRY, DRUG TYPE, AND QUANTITY,
JANUARY- JUNE, 2007
- TABLE 2 (CONTINUED)
- TABLE 2 (CONTINUED)
- Amphetamine-Type Stimulants Market
- Cannabis Market
- Coca/Cocaine Market
- TABLE 3 GLOBAL ILLICIT CULTIVATION OF COCA/COCAINE, 2000- 2007 (MT)
- Opium/Heroin Market
- TABLE 4 GLOBAL ILLICIT CULTIVATION OF OPIUM, 2000- 2007 (MT)
- INTERNATIONAL DRUG TRAFFICKING AND ILLICIT DRUG USE TRENDS BY GEOGRAPHIC
REGION
- Africa
- Central America and Caribbean
- North America
- South America
- East and Southeast Asia
- South Asia
- West Asia
- Europe
- Oceania
- U.S. DRUGS OF ABUSE STATISTICS
- National Household Survey on Drug Abuse: SAMHSA U.S.
- Survey by Age and Drug Type
- TABLE 5 DRUG ABUSE STATISTICS IN THE U.S. BY DRUG TYPE (12 YRS AND
OLDER), 2005 AND 2006 (THOUSANDS)
- Survey by Age 13
- TABLE 6 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS 12 YRS AND OLDER IN
THE U.S. BY AGE, 2005 AND 2006 (THOUSANDS)
- Survey by Gender and Drug Type 15
- TABLE 7 TYPES OF ILLICIT DRUG USE IN LIFETIME AMONG PERSONS 12 YRS AND
OLDER IN THE U.S. BY GENDER, 2005 AND 2006 (THOUSANDS)
- Survey by Race and Ethnicity 15
- TABLE 8 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS 12 YRS AND OLDER IN
THE U.S. BY RACE AND ETHNICITY, 2005 AND 2006 (THOUSANDS)
- TABLE 8 (CONTINUED) 16
- Survey by Geographic Divisions and County Types
- TABLE 9 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS AGED 12 OR OLDER IN
THE U.S. BY GEOGRAPHIC DIVISIONS AND COUNTY TYPES 2005 AND 2006 (THOUSANDS)
- Survey by Education and Current Employment Status
- TABLE 10 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS AGED 12 OR OLDER BY
EDUCATION AND EMPLOYMENT, 2005 AND 2006 (THOUSANDS)
- TABLE 11 U.S. WORKFORCE ANNUAL DRUGS OF ABUSE POSITIVITY RATE, 1990-
2003 (%)
- DRUGS OF ABUSE STATISTICS, AUSTRALIA
- TABLE 12 PROPORTION OF AUSTRALIAN POPULATION USING ILLICIT DRUGS AGED 14
YEARS AND OVER BY DRUG TYPE, 1995-2007 (%)
- DRUGS OF ABUSE STATISTICS, CENTRAL ASIA
- TABLE 13 DRUG ABUSE STATISTICS IN CENTRAL ASIA, 2006
Chapter- 3: DRUGS OF ABUSE TESTING PRACTICES
- SINGLE VS MULTI-PARAMETER TEST
- DOA SCREENING
- CONFIRMATION TESTING
- URINE TESTS
- OTHER TESTING METHODS
- BLOOD TESTING
- ORAL FLUID TESTING
- SALIVA TESTING
- SWEAT TESTING
- HAIR TESTING
- TESTING LOCATIONS
- LABORATORY-BASED DAT
- Criminal Justice
- Police
- Prisons
- Probation
- Workplace Screening
- Military
- Customs and Excise
- Education
- POINT OF CARE DATS
- TABLE 14 ADVANTAGES AND DISADVANTAGES OF POINT OF CARE TESTING
- ONSITE TESTING VS LABORATORY TESTING
- TABLE 15 MAJOR ADVANTAGES AND DISADVANTAGES OF ONSITE TESTING
- SAMPLE TYPES FOR LABORATORY TESTING
- URINE TESTING
- HAIR TESTING
- SALIVA/ORAL FLUID TESTING
- BLOOD TESTING
- SWEAT TESTING
- EYE REFLEX
- DETECTION PERIOD
- TABLE 16 DETECTION PERIODS FOR VARIOUS TYPES OF DRUG TESTING
- FOOLING A DRUG TEST
- FOOLING URINE TESTING
- TABLE 17 COMMON PARAMETERS TESTED FOR URINE SPECIMEN VALIDITY 33
- TABLE 18 SOME OF THE COMMERCIAL/COMMON ADULTERANTS USED IN FOOLING URINE
TESTS AND THEIR EFFECTS
- TABLE 18 (CONTINUED)
- FOOLING HAIR TESTING
- FOOLING SALIVA TESTING
- SAMPLE VALIDITY TESTS
- TABLE 19 URINE SAMPLE VALIDITY TEST METHODS
- TABLE 19 (CONTINUED)
- FALSE POSITIVES AND FALSE NEGATIVES
- FALSE POSITIVES
- TABLE 20 CROSS REACTANTS THAT CAN LEAD TO FALSE POSITIVES IN DOA TESTING
- TABLE 20 (CONTINUED)
- FALSE NEGATIVES
- TESTING TECHNOLOGIES
- IMMUNOASSAYS
- ENZYME IMMUNOASSAY (EIA)
- ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
- ENZYME MULTIPLIED IMMUNOASSAY TECHNOLOGY
- FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA)
- RADIOIMMUNOASSAY (RIA)
- CHROMATOGRAPHY
- Gas Chromatography (GC)
- High Performance Liquid Chromatography (HPLC)
- Thin-Layer Chromatography (TLC)
- Mass Spectrometry (MS)
- Capillary Electrophoresis (CE)
- Hyphenated MS/Chromatography
- Gas-Chromatography-Mass Spectrometry
- EYE REFLEX MEASUREMENTS
- Eye Reflex Measurements (Continued)
Chapter- 4: GOVERNMENT REGULATIONS: DRUG TRAFFICKING AND DRUG ABUSE TESTING
- NORTH AMERICA
- NATIONAL LEGISLATION AND POLICY
- Canada
- Drug Free Workplace
- Mexico 46
- The United States
- Drug-Free Workplace
- TABLE 21 U.S. DRUG TESTING LEGISLATIONS BY STATE, 2008
- TABLE 21 (CONTINUED)
- TABLE 21 (CONTINUED)
- TABLE 21 (CONTINUED)
- TABLE 21 (CONTINUED)
- U.S. Department of Transportation
- Drug Testing in the Military
- SOUTH AMERICA
- NATIONAL LEGISLATION AND POLICY
- Bolivia
- Brazil
- Drug-Free Workplace
- Colombia
- Ecuador
- Guyana
- Paraguay
- Peru 56
- CENTRAL AMERICA AND THE CARIBBEAN
- NATIONAL LEGISLATION AND POLICY
- Costa Rica
- Cuba
- El Salvador
- Guatemala
- Haiti
- Jamaica
- Nicaragua
- Panama
- Tegucigalpa
- The Bahamas
- The Netherlands Antilles
- Trinidad and Tobago
- EUROPE
- NATIONAL LEGISLATION AND POLICY
- Bosnia and Herzegovina
- Denmark
- France
- Germany
- Italy
- Latvia
- Norway
- Romania
- Sweden
- Switzerland
- The Netherlands
- The United Kingdom
- DRUG-FREE WORKPLACE POLICY AND LEGISLATION BY EUROPEAN COUNTRY
- TABLE 22 DRUG-TESTING LEGISLATION BY EUROPEAN COUNTRY, 2008
- TABLE 22 (CONTINUED)
- TABLE 22 (CONTINUED)
- TABLE 22 (CONTINUED)
- ASIA PACIFIC
- NATIONAL LEGISLATION AND POLICY
- Australia
- Bangladesh
- Bhutan
- Cambodia
- Hong Kong
- India
- The NDPS (Regulation of Controlled Substances) Order, 1993
- Japan
- Maldives
- Myanmar
- Nepal
- New Zealand
- Singapore
- South Korea
- Sri Lanka
- Taiwan
- Thailand
- Vietnam
Chapter- 5: GLOBAL DRUGS OF ABUSE TESTING MARKET BY SAMPLE MATRIX
- DRUGS OF ABUSE TESTING SALES 77
- TABLE 23 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SAMPLE
MATRIX, THROUGH 2014 ($ MILLIONS)
- FIGURE 1 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SAMPLE
MATRIX, 2006- 2014 ($ MILLIONS)
- GLOBAL SALES OF DRUGS OF ABUSE TESTING BY URINE
- TABLE 24 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE,
THROUGH 2014 ($ MILLIONS/%)
- FIGURE 2 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE,
2006- 2014 ($ MILLIONS)
- TABLE 25 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE:
LABORATORY BASED VERSUS ONSITE, THROUGH 2014 ($ MILLIONS)
- FIGURE 3 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE:
LABORATORY BASED VERSUS ONSITE, 2007 (%)
- GLOBAL SALES OF DRUGS OF ABUSE TESTING BY BLOOD
- TABLE 26 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY BLOOD,
THROUGH 2014 ($ MILLIONS/%)
- FIGURE 4 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY BLOOD,
2006- 2014 ($ MILLIONS)
- GLOBAL SALES OF DRUGS OF ABUSE TESTING BY ORAL FLUID
- TABLE 27 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL FLUID,
THROUGH 2014 ($ MILLIONS/%)
- FIGURE 5 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL
FLUID, 2006- 2014 ($ MILLIONS)
- TABLE 28 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL
FLUID: LABORATORY BASED VERSUS ONSITE, THROUGH 2014 ($ MILLIONS)
- FIGURE 6 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL:
LABORATORY BASED VERSUS ONSITE, 2006 AND 2014 (%)
- GLOBAL SALES OF DRUGS OF ABUSE TESTING BY HAIR
- TABLE 29 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY HAIR,
THROUGH 2014 ($ MILLIONS/%)
- FIGURE 7 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY HAIR,
2006- 2014 ($ MILLIONS)
- GLOBAL SALES OF DRUGS OF ABUSE TESTING BY SWEAT
- TABLE 30 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SWEAT,
THROUGH 2014 ($ MILLIONS/%)
- FIGURE 8 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SWEAT,
2006- 2014 ($ MILLIONS)
- GLOBAL SALES OF DRUGS OF ABUSE TESTING BY OTHER SAMPLE MATRICES
- TABLE 31 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY OTHER
SAMPLE MATRICES, THROUGH 2014 ($ MILLIONS/%)
- FIGURE 9 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY OTHER
SAMPLE MATRICES, 2006- 2014 ($ MILLIONS)
Chapter- 6: WORLDWIDE INDUSTRY STRUCTURE
- REGIONAL ANALYSIS
- FIGURE 10 DRUGS OF ABUSE TESTING MARKETS BY GEOGRAPHIC REGIONS, 2007 (%)
- FIGURE 10 (CONTINUED)
- TOTAL DOA TESTING AND DRUG MONITORING MARKETS AND FORECASTS
- TABLE 32 GLOBAL DRUGS OF ABUSE TESTING MARKET FORECAST, THROUGH 2014 ($
MILLIONS/%)
- TABLE 33 DRUGS OF ABUSE TESTING BY LABORATORY, ONSITE, AND HOME TESTING
MARKET FORECAST, 2006- 2014 ($ MILLIONS/%)
- GROWTH TRENDS - LABORATORY BASED AND ONSITE DOA TESTING MARKETS
- LABORATORY-BASED DOA TESTING MARKETS AND FORECASTS
- TABLE 34 DRUGS OF ABUSE TESTING MARKET FORECAST FOR LABORATORY-BASED
TESTING, 2006- 2014 ($ MILLIONS/%)
- ONSITE DOA TESTING MARKETS AND FORECASTS
- TABLE 35 DRUGS OF ABUSE TESTING MARKET FORCAST FOR ONSITE TESTING,
THROUGH 2014 ($ MILLIONS/%)
- COMPETITIVE ANALYSIS
- TABLE 36 MOST NOTABLE MERGERS AND ACQUISITIONS IN THE DOA TESTING
MARKETS, 2000- 2007
- Key Market Players in the DOA Testing Markets and Their Products
- TABLE 37 MAJOR COMPANIES AND THEIR PRODUCTS IN THE DOA TESTING MARKET
- LABORATORY-BASED DOA TESTING MARKET SEGMENT
- TABLE 38 COMPANIES OFFERING LABORATORY-BASED DOA TESTING PRODUCTS
- TABLE 38 (CONTINUED)
- ONSITE TESTING MARKET SEGMENT FOR DOA
- TABLE 39 MAIN ONSITE DOA TESTING MARKET PLAYERS AND THEIR PRODUCTS
- TABLE 39 (CONTINUED)
- COMMON DRUGS OF ABUSE AND MOST POPULAR DEVICES USED FOR TESTING THEM
- TABLE 40 COMMON DOA AND POPULAR URINE DRUG SCREENING PRODUCTS
- TABLE 40 (CONTINUED)
- COMPANIES IN THE ORAL FLUID, HAIR, AND SWEAT TESTING SEGMENTS FOR DOA
- TABLE 41 KEY MARKET PLAYERS OFFERING DOA TESTING PRODUCTS ON ORAL FLUID,
HAIR, AND SWEAT SAMPLE MATRICES
- COMPANY PROFILES
- ABBOTT LABORATORIES
- Abbott Hematology - Diagnostics Division
- ACON LABORATORIES, INC.
- AMERICAN BIO MEDICA CORP. (ABMC)
- AVITAR, INC.
- BECKMAN COULTER
- BIO-RAD LABORATORIES, INC
- CONCATENO, PLC
- F. HOFFMANN-LA ROCHE, LTD.
- INVERNESS MEDICAL INNOVATIONS, INC.
- MEDTOX SCIENTIFIC, INC.
- MICROGENICS
- NANOGEN, INC.
- OLYMPUS DIAGNOSTICS SYSTEMS
- ORASURE TECHNOLOGIES, INC.
- SIEMENS MEDICAL SOLUTIONS USA, INC.
- VARIAN, INC.
- Varian, Inc. (Continued)
Chapter- 7: PATENT ANALYSIS
- TABLE 42 U.S. DRUGS OF ABUSE TESTING PATENTS BY ASSIGNEE, 1978- 2007
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
Chapter- 8: APPENDIX
- TABLE 43 GLOSSARY OF COMMON TERMS
- TABLE 43 (CONTINUED)
- TABLE 43 (CONTINUED)
- TABLE 43 (CONTINUED)
- TABLE 43 (CONTINUED)
- TABLE 44 GLOSSARY OF SCIENTIFIC ABBREVIATIONS
- TABLE 45 ASSOCIATIONS
|
Related Report
|
View Cart
